1. Home
  2. COLD vs NAMS Comparison

COLD vs NAMS Comparison

Compare COLD & NAMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Americold Realty Trust Inc.

COLD

Americold Realty Trust Inc.

HOLD

Current Price

$12.28

Market Cap

3.4B

Sector

Real Estate

ML Signal

HOLD

Logo NewAmsterdam Pharma Company N.V.

NAMS

NewAmsterdam Pharma Company N.V.

HOLD

Current Price

$28.58

Market Cap

3.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
COLD
NAMS
Founded
1903
2019
Country
United States
Netherlands
Employees
12690
100
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.3B
IPO Year
2009
N/A

Fundamental Metrics

Financial Performance
Metric
COLD
NAMS
Price
$12.28
$28.58
Analyst Decision
Hold
Strong Buy
Analyst Count
16
8
Target Price
$14.97
$46.75
AVG Volume (30 Days)
2.9M
861.9K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
7.67%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,601,846,000.00
N/A
Revenue This Year
N/A
$17.96
Revenue Next Year
$2.86
$540.65
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.10
$16.79
52 Week High
$19.68
$42.00

Technical Indicators

Market Signals
Indicator
COLD
NAMS
Relative Strength Index (RSI) 51.43 36.74
Support Level $11.98 $23.48
Resistance Level $13.08 $37.25
Average True Range (ATR) 0.42 1.76
MACD -0.01 -0.65
Stochastic Oscillator 35.78 8.22

Price Performance

Historical Comparison
COLD
NAMS

About COLD Americold Realty Trust Inc.

Americold Realty Trust Inc is the world's second-largest owner and operator of temperature-controlled warehouses behind privately held Lineage Logistics. The Atlanta, Georgia-based firm owns and operates approximately 231 temperature-controlled warehouses, spanning 1.4 billion cubic feet. In 2022, the firm derived more than 80% of its revenue from the United States but also has sizable operations in Europe, Canada, Australia, and New Zealand. Americold supplements its core business by providing supply management and transportation services to its various customers. It operates as a real estate investment trust.

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

Share on Social Networks: